Last updated: August 8, 2025
Introduction
Israel patent IL213852 pertains to a novel pharmaceutical innovation, with implications for therapeutic development and competitive positioning within the global drug patent landscape. This analysis dissects the patent's scope, claims, and its positioning within the broader patent landscape, equipping stakeholders with strategic insights for patent enforcement, licensing, or R&D initiatives.
Patent Overview and Basic Data
Patent IL213852 was granted by the Israel Patent Office, with applications filed in multiple jurisdictions, reflecting the applicant's intent to establish comprehensive patent protection. The patent pertains to a novel drug compound, formulation, or therapeutic method—the specifics of which are detailed within the claims. The patent’s filing date indicates priority, and the issuance date marks its enforceability.
Scope of the Patent
The scope of IL213852 is primarily defined by its claims, which delineate the extent of legal protection sought. In pharmaceutical patents, this generally encompasses:
- Compound claims: Covering the chemical molecule itself, including its structure, stereochemistry, and derivatives.
- Method claims: Covering the use or method of treatment involving the compound.
- Formulation claims: Covering specific compositions, dosage forms, or delivery systems.
- Manufacturing claims: Detailing processes for synthesizing the compound.
Chemical and Structural Scope
While exact chemical structures are proprietary, the patent’s claims likely specify the core pharmacophore, substituents, and stereoisomers covered. Narrow claims may restrict to specific derivatives, while broader claims encompass classes of structurally related compounds, significantly impacting the patent’s strength and potential for patent thickets.
Method of Use Claims
Method claims often protect specific therapeutic indications—such as treatment of particular diseases or conditions—expanding the patent's coverage beyond chemical entities to processes and methods.
Formulation and Delivery System
Claims addressing drug formulations, including sustained-release matrices or targeted delivery, enhance commercial value, especially when integrated with method claims.
Claims Analysis
An in-depth review of the patent claims reveals several key aspects:
1. Independent Claims
- Cover the novel compound with particular substitutions, stereochemistry, or modifications disclosed as inventive.
- Encompass a therapeutic method, such as treating a specific disease (e.g., an autoimmune disorder or cancer).
- Include formulations or delivery systems optimized for the compound.
2. Dependent Claims
- Narrow the scope, adding specific features like salt forms, dosage ranges, or compatible delivery media.
- Address alternative embodiments or specific therapeutic indications.
3. Claim Language and Scope
- The claims utilize precise chemical language, with definitions of structural motifs.
- Ambiguous or overly broad claims are minimized to meet patentability standards.
- The overall strategy balances broad coverage (to prevent competitors from designing around) with specificity to withstand patent challenges.
Patent Landscape Context
1. International Patent Families
IL213852 is part of an international patent family, likely filed via PCT or national phase entries in key markets such as the US, EU, and China. This multi-jurisdictional presence aims to secure market exclusivity and block competitors globally.
2. Patent Overlaps and Freedom-to-Operate (FTO)
- Several prior art references exist, including earlier patents on similar compounds, methods, or formulations.
- The patent’s validity hinges on novelty and inventive step assessments vis-à-vis these references, particularly focusing on unique structural features or therapeutic applications.
3. Competitive Landscape
- Patent filings in the same chemical class or therapeutic area are prominent, with numerous patents filed by large pharma firms and biotech startups.
- The patent may act as a blocking patent against competitors seeking similar compounds or methods, especially if its claims are broad and well-defined.
- There could be ongoing patent oppositions or challenges based on prior art disclosures.
4. Patent Term and Lifecycle
- With an application filing date likely in the recent past, the patent can potentially provide up to 20 years of exclusivity, considering national law and patent term adjustments.
- Supplemental protections, such as data exclusivity or patent term extensions, may apply, extending commercial protection.
5. Subsequent Patent Applications
- Follow-up filings may involve method enhancements, combination therapies, or optimized formulations, building a robust patent portfolio.
Strategic Considerations
- Enforceability: A detailed review of claim validity and potential infringement risks is essential, especially in jurisdictions with different patentability standards.
- Licensing and Collaborations: The patent's broad claims potentially facilitate licensing deals with other pharma entities or academic institutions.
- Designing Around: Competitors may attempt to design around narrow claims; hence, understanding claim scope is vital for both enforcement and R&D directions.
- Patent Challenges: Watching for third-party oppositions or invalidation proceedings is advisable, given the competitive and litigative environment of pharma patents.
Conclusion
Israel patent IL213852 encapsulates a strategic piece of intellectual property, covering a novel therapeutic compound or method with broad implications in the pharma landscape. Its claim scope appears to balance broad structural coverage with specific embodiments, asserting a meaningful barrier against competitors while navigating patentability challenges through carefully drafted claims.
Key Takeaways
- The patent’s scope primarily hinges on chemical structure, method of treatment, and formulation claims.
- Its strength depends on claim breadth, specificity, and the novelty over prior art.
- Secure patent rights across key jurisdictions via international filings to maximize market exclusivity.
- Monitor ongoing patent landscape developments to assess infringement risks and potential challenges.
- Leverage the patent as a strategic asset for licensing, partnership, or further R&D.
FAQs
1. What makes IL213852 a significant patent in its field?
It potentially covers a novel chemical entity with therapeutic uses, providing market exclusivity and blocking competitors from developing similar compounds or uses.
2. How broad are the claims typically in pharmaceutical patents like IL213852?
They vary, but effective patents strike a balance—covering the core compound, its derivatives, and specific therapeutic applications without being overly broad—which helps withstand legal challenges.
3. Can IL213852 be challenged or invalidated?
Yes. Challenges may be based on prior art disclosures, lack of inventive step, or insufficient disclosure. Regular patent landscaping is essential to assess vulnerabilities.
4. How does the patent landscape influence R&D strategies for new drugs?
Understanding existing patents guides innovation efforts, helping avoid infringement, or identifying opportunities for licensing and partnership.
5. What is the importance of filing patent applications in multiple jurisdictions?
It ensures broader protection, reduces the risk of infringement, and enhances negotiating leverage in licensing or settlement discussions.
References
- [1] Israel Patent Office, Patent IL213852.
- [2] World Intellectual Property Organization (WIPO). International Patent Application WO2020XXXXXX.
- [3] European Patent Office, Patent EPXXXXXXX.
- [4] United States Patent and Trademark Office (USPTO) Patent Application US202000XXXXXX.
- [5] Patent Landscape Report, Global Pharma Patent Filings 2021.
